Double-Duty immune attack: new hope for kids with tough cancers
NCT ID NCT07257419
Summary
This study is testing a new two-step treatment for children and young adults with a specific type of leukemia or lymphoma that has come back or hasn't responded to other treatments. First, patients receive a stem cell transplant from a partially matched family donor. Then, they receive an additional boost of specially engineered immune cells (CAR T-cells) designed to target and fight the cancer. The main goal of this early-phase study is to see if combining these two powerful treatments is safe and possible to do.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Jude Children's Research Hospital
RECRUITINGMemphis, Tennessee, 38105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.